Thrivent Financial for Lutherans
NVRO

Thrivent Financial for Lutherans’s NEVRO CORP. NVRO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-281,256
Closed -$22.8M – 2552
2021
Q4 		$22.8M Sell
281,256
-6,103
-2% -$612K 0.04% 436
2021
Q3 		$33.4M Buy
287,359
+18,304
+7% +$2.4M 0.07% 320
2021
Q2 		$44.6M Buy
269,055
+11,199
+4% +$1.75M 0.09% 268
2021
Q1 		$36M Buy
257,856
+28,935
+13% +$4.72M 0.08% 295
2020
Q4 		$39.6M Sell
228,921
-24,802
-10% -$4.02M 0.09% 282
2020
Q3 		$35.3M Sell
253,723
-6,838
-3% -$914K 0.09% 256
2020
Q2 		$31.1M Buy
260,561
+176,111
+209% +$20.9M 0.09% 266
2020
Q1 		$8.44M Buy
84,450
+32,635
+63% +$3.93M 0.03% 537
2019
Q4 		$6.09M Buy
51,815
+5,470
+12% +$542K 0.02% 690
2019
Q3 		$3.98M Buy
46,345
+1,346
+3% +$102K 0.01% 738
2019
Q2 		$2.92M Buy
44,999
+569
+1% +$35.4K 0.01% 835
2019
Q1 		$2.78M Sell
44,430
-39,676
-47% -$1.87M 0.01% 826
2018
Q4 		$3.27M Sell
84,106
-78,218
-48% -$3.48M 0.01% 709
2018
Q3 		$9.25M Sell
162,324
-19,541
-11% -$1.22M 0.03% 510
2018
Q2 		$14.5M Sell
181,865
-30,265
-14% -$2.51M 0.05% 390
2018
Q1 		$18.4M Buy
212,130
+1,870
+0.9% +$151K 0.06% 310
2017
Q4 		$14.5M Hold
210,260
– – 0.05% 361
2017
Q3 		$19.1M Hold
210,260
– – 0.07% 272
2017
Q2 		$15.7M Buy
210,260
+10,030
+5% +$804K 0.07% 284
2017
Q1 		$18.8M Buy
200,230
+7,960
+4% +$721K 0.08% 241
2016
Q4 		$14M Buy
192,270
+45,820
+31% +$3.92M 0.06% 306
2016
Q3 		$15.3M Buy
146,450
+17,050
+13% +$1.54M 0.07% 284
2016
Q2 		$9.54M Buy
129,400
+21,600
+20% +$1.47M 0.05% 386
2016
Q1 		$6.07M Buy
+107,800
New +$6.36M 0.03% 521

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Thrivent Financial for Lutherans's NVRO Position: Q1 2022 in Review

Thrivent Financial for Lutherans sold out of NEVRO CORP. (NVRO) in Q1 2022, closing a stake of 281,256 shares — an estimated $22.8M sold.

Thrivent Financial for Lutherans first reported a position in NVRO in Q1 2016 and held it in 24 quarters. The position peaked at $44.6M in Q2 2021. 195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

  • Thrivent Financial for Lutherans reported no remaining NEVRO CORP. position as of Q1 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 281,256 NEVRO CORP. shares in Q1 2022, an estimated $22.8M.
  • Thrivent Financial for Lutherans first reported a position in NEVRO CORP. in Q1 2016 and held it in 24 quarters.
  • Thrivent Financial for Lutherans's NEVRO CORP. position peaked at $44.6M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2022, filed 13 May 2022.